上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1292Please respect copyright.PENANA9YQz3m269y
1292Please respect copyright.PENANAyrQ9kek3tu
上集:https://www.penana.com/article/4711251292Please respect copyright.PENANA7rXXsE4TQM
1292Please respect copyright.PENANAmrSjFKMhWm1292Please respect copyright.PENANAAyKVOkdnrG
1292Please respect copyright.PENANAeskArIZWAQ
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1292Please respect copyright.PENANA6yRAWbLcBj
1292Please respect copyright.PENANAq8vn1HJr6s
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1292Please respect copyright.PENANAp1XLNE7trW
1292Please respect copyright.PENANAgHKUX8qFAX
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1292Please respect copyright.PENANA1iRMAEmpXx
1292Please respect copyright.PENANAKjltrSVd621292Please respect copyright.PENANARtzAoVeDyt
1292Please respect copyright.PENANAok7tNXTXqe
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1292Please respect copyright.PENANAEXu6tfuPS0
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1292Please respect copyright.PENANA6mFBEBzfjx
1292Please respect copyright.PENANARv7Wvr9d8T
忘記甚麼是Neoantigen的話,可重溫上一集。1292Please respect copyright.PENANAebywDpvC1z
1292Please respect copyright.PENANAx4YwK7nyJr
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1292Please respect copyright.PENANAYfgLAYLXoq
1292Please respect copyright.PENANAiadr1ZOpAp
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1292Please respect copyright.PENANA0CyKkAqq4t
1292Please respect copyright.PENANAao63UFDAIL1292Please respect copyright.PENANAbqM32vnXgS
1292Please respect copyright.PENANAFoMt6DRFax
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1292Please respect copyright.PENANAn5Ihr293Uq
1292Please respect copyright.PENANAKH7HteI5W3
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1292Please respect copyright.PENANAJ3KOjkqzrE
1292Please respect copyright.PENANAqK0nUiAquh
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1292Please respect copyright.PENANAAm5S7ceTEH1292Please respect copyright.PENANAY6JPU2DDGu
1292Please respect copyright.PENANAkXxmNvivDk
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1292Please respect copyright.PENANA7ybmtG0kfM
1292Please respect copyright.PENANAPzHwhBiQGk
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1292Please respect copyright.PENANAxr6jzreNEx1292Please respect copyright.PENANAFUHZMIRR9H
1292Please respect copyright.PENANANGNqkqkA0H
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1292Please respect copyright.PENANAFIHbvVjej5
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1292Please respect copyright.PENANAMkqHh08u6K
1292Please respect copyright.PENANA7GrFHRoOuE
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1292Please respect copyright.PENANAqcdfhIvDtP
1292Please respect copyright.PENANAIHBeKkSRfq
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1292Please respect copyright.PENANAOfd4B5jper
1292Please respect copyright.PENANAvaLbpaKnl7
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1292Please respect copyright.PENANApdTD51ePRO
1292Please respect copyright.PENANAA7l0BhIprz
1292Please respect copyright.PENANAzBJArZiJ16
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1292Please respect copyright.PENANAlBtceOAE1s
1292Please respect copyright.PENANAiy3hOSsP59
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1292Please respect copyright.PENANAHOgpoD9D2X
1292Please respect copyright.PENANAv385oBMqAB
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1292Please respect copyright.PENANAMH72TAT9eJ
1292Please respect copyright.PENANAe7SX3Klz3b
Link:1292Please respect copyright.PENANABHTk8Hf42n
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1292Please respect copyright.PENANAp4Nvo4iJGe
1292Please respect copyright.PENANAb7hWyv3JJs
1292Please respect copyright.PENANA2AqBR5hTE3
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1292Please respect copyright.PENANAzRweuwhHPa